UNSPSC 51422319: Fluperolone

This classification denotes a fluprednisolone analog and pregnadienetriol, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S33056JLS5. European Medicines Agency schedules Fluperolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07729MIG. Fluperolone generally arises in the molecular formula C22H29FO5.

The term FLUPEROLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) FLUPEROLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluperolone under HS 29372200 and SITC 54153. As of Q4 2014, FLUPEROLONE remains the US FDA Preferred Term for this commodity. SMILES: CC(C(=O)C1(CCC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)O)O.

UNSPSC 51422319 Fluperolone is a Commodity code that shows minimal alignment with actual recent state and local procurement activity. The code nominally describes a pharmaceutical compound, but the two recent opportunities tagged to it—a Seminole County, Florida procurement for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs—do not represent fluperolone acquisition. The Seminole County solicitation seeks naloxone (an opioid antagonist used in overdose response) and deactivation equipment for community health delivery, while the Texas HHS RFI explores pharmacy benefit program restructuring and direct contracting with manufacturers for prescription fulfillment. Neither opportunity involves fluperolone as a product or service line. State and local issuers tagging opportunities to this code appear to be using it as a catch-all for pharmaceutical-adjacent procurement rather than as a descriptor of actual fluperolone demand.

No recent state and local solicitations specifically procuring fluperolone have been identified in the source material. The geographic distribution of the two misaligned opportunities spans Florida and Texas, but these do not signal meaningful market activity under the code itself. Business development professionals evaluating pursuit under UNSPSC 51422319 should treat this as a low-activity code with current tagging inconsistency and verify directly with issuing bodies whether fluperolone represents an actual procurement need before investing sales and proposal resources.